Prognostic Value of the Delivery Dialysis Dose on Twice-Weekly Hemodialysis Patients.

CONCLUSIONS: Higher spKt/V is also associated with MACE-free survival and better HR-QOL, especially in physical function aspect for twice-weekly dialysis patients. Increasing spKt/V over 1.70 in twice-weekly HD population does not cause loss of RKF. PMID: 28171855 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28171855?dopt=Abstract

Source: American Journal of Nephrology - February 7, 2017 Category: Urology & Nephrology Authors: Fan Q, Yan Y, Gu L, He L, Chen N, Jiang G, Yuan L, Xue J, Zhang Y, Ma J, Jin H, Yuan W, Guo Z, Guo L, Wang N, Zhang W, Ye Z, Mao P, Pi X, Lu R, Zhu M, Zhang W, Ni Z, Qian J, Pang H Tags: Am J Nephrol Source Type: research